GlassScriptPhysician profile
Sofia Mckenzie Vacca
NPI 1841966710
$1,320.62
in general payments reported to CMS, 2019-2025
20 companies · $26.84 in 2025
The $26.84 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $371 · 2024: $923 · 2025: $26.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $271.09 | 2024 | Keytruda, Lynparza |
| Myriad Genetic Laboratories, INC. | $148.31 | 2023-2024 | Prolaris |
| Procept Biorobotics Corporation | $89.57 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Abbvie INC. | $85.39 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $75.63 | 2024 | |
| Urogen Pharma, INC. | $75.28 | 2023-2024 | Jelmyto |
| Ferring Pharmaceuticals INC. | $71.38 | 2024 | Adstiladrin |
| 180 Medical, INC. | $55.89 | 2023 | Gentlecath Glide, Gentlecath |
| Sumitomo Pharma America, INC. | $54.08 | 2024 | Gemtesa |
| Coloplast Corp | $53.33 | 2024 | |
| Tolmar, INC. | $52.83 | 2023 | |
| Endo USA, INC. | $46.91 | 2024 | Xiaflex, Aveed |
| Teleflex LLC | $44.46 | 2023 | Urolift |
| Endo Pharmaceuticals INC. | $43.75 | 2024 | Xiaflex, Aveed |
| Abc Home Medical Supply, INC. | $40.22 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $29.71 | 2024 | Provenge |
| Blue Earth Diagnostics | $29.17 | 2024 | |
| Immunitybio, INC. | $22.41 | 2024 | |
| Calyxo, INC. | $17.33 | 2024 | Cvac Aspiration System |
| Janssen Biotech, INC. | $13.88 | 2024 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Vacca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.